Skip to main content
Figure 2 | Cardiovascular Diabetology

Figure 2

From: Effects of 24-week treatment with acarbose on glucagon-like peptide 1 in newly diagnosed type 2 diabetic patients: a preliminary report

Figure 2

Difference of serum nitric oxide, NOS activity and CIMT between pre- and post-acarbose treatment. NOS: nitric oxide synthase; CIMT: carotid intima-media thickness; A: all of the subjects; B: the subjects with decreased postprandial GLP-1 following acarbose treatment; C: the subjects with increased postprandial GLP-1 following acarbose treatment; *p < 0.05 for the difference between the pre- and post-acarbose treatment.

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840